雅培Abbott Laboratories （ABT）2024年年度报告「NYSE」（英文版）（86页）.pdf

1、2024 ANNUAL REPORTFRONT COVER:Her mother knew early in her life that something in Trinitys body wasnt working right.When Trinity was diagnosed with Type 1 diabetes,it started a journey to a better understanding of the impact of food and exercise on her health.TABLE OF CONTENTS1 Letter to Shareholder

2、s5 The Abbott we have built6 Delivering now8 Designing whats next10 Neuromodulation12 Structural Heart14 Electrophysiology16 Vascular18 Cardiac Rhythm Management20 Heart Failure Management22 Diabetes Care24 Biowearables26 Nutrition28 Medicines30 Rapid Diagnostics32 Laboratory Diagnostics34 Passion a

3、nd purpose36 Financial ReportAbbott is a global healthcare leader,with 114,000 employees serving people in more than 160 countries.We have balanced leadership across diverse markets and geographies with businesses and products in medical devices,diagnostics,nutritionals,and medicines giving us more

4、ways to succeed and greater resilience as markets and economies evolve.Our unwavering focus on helping people get healthy and stay that way,at all stages of life,has helped us deliver consistent,sustainable growth and shareholder returns.Trinity LindbladeWALKERSVILLE,MARYLAND,USAFREESTYLE LIBRE 3 SY

5、STEMFreeStyle Libre 3 systemFew companies can demonstrate the full range of benefits that business brings to society as powerfully as Abbott.Our performance in 2024 embodied that broad value and the many strengths that make it possible.DEAR FELLOW SHAREHOLDER:ROBERT FORD Chairman of the Board and Ch

6、ief Executive Officer2A B B OT T 2024 A N N UA L R E P O R TCONTINUED,CONSISTENT GROWTH IN 20249.6%ORGANIC SALES GROWTH,UNDERLYING BASE BUSINESS$4.67ADJUSTED DILUTED EPS$42BWORLDWIDE SALES A HEALTHY BALANCE One of the best-known axioms in politics is,“Its the economy,stupid.”Its a pragmatic reminder